1. Abbas, T. and Dutta, A. (2009): p21 in cancer: intricate networks and multiple activities. Nat. Rev. Cancer, 9, 400-414.
2. Afrin, S., Giampieri, F., Gasparrini, M., Forbes-Hernandez, T.Y., Varela-López, A., Quiles, J.L., Mezzetti, B. and Battino, M. (2016): Chemopreventive and Therapeutic Effects of Edible Berries: A Focus on Colon Cancer Prevention and Treatment. Molecules, 21, 169.
3. Arnold, M., Sierra, M.S., Laversanne, M., Soerjomataram, I., Jemal, A. and Bray, F. (2017): Global patterns and trends in colorectal cancer incidence and mortality. Gut, 66, 683-691.
4. Asghar, U., Witkiewicz, A.K., Turner, N.C. and Knudsen, E.S. (2015): The history and future of targeting cyclin-dependent kinases in cancer therapy. Nat. Rev. Drug Discov., 14, 130-146.
5. Borkan, S.C. (2016): The Role of BCL-2 Family Members in Acute Kidney Injury. Semin. Nephrol., 36, 237-250.